Global Monocyanamide Market Strategic Research Report
By Type: 30% Solution, 50% Solution, ≥95% Crystals, Others
By Application: Pesticide Intermediate, Plant Growth Regulator, Pharmaceutical Intermediate, Others
Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America
Key Players: AlzChem Group AG (DE), Nippon Carbide Industries Co., Ltd. (JP), Ningxia Darong Industrial Group Co., Ltd. (CN), Jiangsu Deda Petrochemical Technology Co., Ltd. (CN), Rugao Zhongru New Material Technology Co., Ltd. (CN), Yifeng New Materials Co., Ltd. (CN), Ningxia Jiafeng Chemical Co., Ltd. (CN), Shanxi Zhicheng Chemical Co., Ltd. (CN), Ningxia Jinhaiyangguang Biotechnology Co., Ltd. (CN), Ningxia Jinhua Chemical Co., Ltd. (CN), Pingluo County Xiangmei Chemical Co., Ltd. (CN), Ningxia Hengkang Technology Co., Ltd. (CN), Ningxia Taikang Pharmaceutical Co., Ltd. (CN), Ningxia Sikeda Biotechnology Co., Ltd. (CN), Shanghai Baosui Chemical Co., Ltd. (CN), Shandong Qiangsen Chemical Co., Ltd. (CN), Jiangsu Xinsu New Materials Co., Ltd. (CN), Suzhou Senfeida Chemical Co., Ltd. (CN)
Vue d'ensemble
Scope of the Report
The global Monocyanamide market size is predicted to grow from US$ 206 million in 2025 to US$ 289 million in 2032; it is expected to grow at a CAGR of 5.3% from 2026 to 2032.
Cyanamide is a crucial nitrogen-containing intermediate in the fine chemical industry. Commonly available in the form of aqueous solutions or crystals, it exhibits high chemical reactivity. It serves as a key precursor for the synthesis of pharmaceutical intermediates, pesticide intermediates, dye auxiliaries, electronic chemicals, resin modifiers, rubber additives, and plant growth regulators. Furthermore, it acts as a fundamental raw material for the production of dicyandiamide, guanidine compounds, and various nitrogen-containing heterocyclic compounds. In 2025, global sales volume is projected to reach approximately 136,000 tons, with an average unit price of approximately US$2,550 per ton and a capacity utilization rate of approximately 72%. Upstream suppliers primarily consist of manufacturers of calcium cyanamide, liquid ammonia, carbon dioxide, sulfuric acid, and purified water, as well as providers of stabilizers, cooling equipment, hazardous chemical packaging, and specialized logistics services. Downstream consumers are predominantly enterprises involved in pharmaceutical intermediates, technical-grade pesticides, fine chemical synthesis, electronic chemicals, rubber and plastic additives, resin materials, and agricultural inputs. The product maintains a gross profit margin of approximately 29%. Regarding its cost structure, calcium cyanamide (or cyanamidation raw materials) accounts for 36%; acidification and hydrolysis auxiliaries for 12%; stabilizers and purification treatments for 8%; reaction energy consumption and cooling costs for 10%; labor and equipment depreciation for 7%; quality control testing for 5%; hazardous chemical packaging and logistics for 10%; and environmental treatment and other miscellaneous expenses for 12%. The demand profile encompasses requirements for the synthesis of pharmaceutical and pesticide intermediates, the production of guanidine compounds, resin and rubber additives, raw materials for electronic chemicals, supporting inputs for agricultural regulators, and high-purity nitrogen-containing chemicals. The downstream client base includes manufacturers of active pharmaceutical ingredients (APIs), technical-grade pesticides, fine chemicals, electronic chemicals, rubber additives, resin modifiers, research reagents, and agricultural chemicals. In terms of business opportunities, policy-driven factors stem primarily from the high-end upgrading of fine chemicals, the structural enhancement of pesticide products, the domestic substitution of pharmaceutical intermediates, the standardized production of hazardous chemicals, and increasingly stringent environmental regulations. Technological innovation is driven mainly by advancements in continuous reaction processes, high-purity separation techniques, low-byproduct synthesis methods, stabilized storage and transport technologies, low-temperature safety controls, and efficient wastewater treatment. Changes in consumer demand are manifested in customers placing greater emphasis on product purity, the control of dicyandiamide impurities, batch-to-batch consistency, regulatory documentation, safe transportation, and reliable long-term supply; these factors are driving the development of cyanamide production toward greater purity, stability, specialization, and eco-friendly practices.
Monocyanoamide is a product within the fine chemicals sector that serves as both a foundational intermediate and a specialized chemical. Its demand does not rely solely on a single downstream application but is collectively supported by diverse sectors—including pharmaceuticals, agrochemicals, guanidine compounds, resin additives, and electronic chemicals—thereby endowing its overall market demand with a certain degree of resilience. Around 2025, the pricing of standard industrial-grade monocyanoamide is expected to be significantly influenced by the costs of calcium cyanamide, liquid ammonia, energy, and environmental compliance; consequently, price fluctuations are likely to be relatively pronounced. Corporate profitability in this segment will depend primarily on integrated raw material supply, reaction yields, wastewater treatment capabilities, and the efficiency of hazardous chemical logistics. In contrast, high-purity grades, low-dicyandiamide variants, and products with strictly controlled impurity profiles rely more heavily on purification processes, stabilizer systems, storage safety protocols, and customer validation; as a result, these specialized products command gross margins significantly higher than those of standard grades. From 2026 to 2032, the global sales volume is projected to grow at an average annual rate of approximately 4% to 6%, with demand growth in pharmaceutical intermediates, agrochemical intermediates, and electronic chemicals expected to outpace that of traditional additive sectors. Chinese enterprises hold advantages in terms of basic production capacity and cost control, yet they still have room for improvement regarding high-purity specifications, stabilized transportation, and securing certifications from high-end clientele. Conversely, international enterprises tend to place greater emphasis on safety management, quality documentation, and specialized product services. Future opportunities within the industry are expected to center on three key areas: first, enhancing safety and reaction yields through continuous-flow processing and automation; second, gaining entry into the supply chains of pharmaceutical, electronics, and high-end fine chemical clients by offering high-purity products with stringent impurity controls; and third, bolstering customer loyalty by optimizing hazardous chemical warehousing and regional distribution capabilities. Overall, monocyanoamide is not merely a simple commodity chemical; rather, safe production practices, environmentally responsible waste treatment, purity control, and supply stability will be the decisive factors determining a company's long-term competitiveness. Enterprises possessing integrated raw material supply chains, robust quality management systems, and specialized product development capabilities are best positioned to secure stable profits.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Monocyanamide market?
What factors are driving Monocyanamide market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Monocyanamide market opportunities vary by end market size?
How does Monocyanamide break out by Type, by Application?
This report presents a comprehensive overview of the global Monocyanamide market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.
Segment by Type
- 30% Solution
- 50% Solution
- ≥95% Crystals
- Others
Segment by Dicyandiamide Content
- ≤1% HPLC
- ≤1.5% HPLC
- ≤2% HPLC
Segment by Application
- Pesticide Intermediate
- Plant Growth Regulator
- Pharmaceutical Intermediate
- Others
Who Can Use This Report?
This report is written for decision-makers who need a clear, data-backed view of the global Monocyanamide market:
- Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
- Distributors, channel partners and end users in Pesticide Intermediate, Plant Growth Regulator, Pharmaceutical Intermediate evaluating demand and sourcing options
- Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
- Government agencies, industry associations and research institutions tracking industry developments and policy impact
Market snapshot
Global Monocyanamide Market Strategic Research Report snapshot, 2025–2032
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.Segments covered in this report
Table of contents
01Executive Summary
02Industry Overview & Forecast
- 2.1.1 Market Definition and Scope
- 2.1.2 Market Size and Growth Forecast
- 2.1.3 Volume Analysis
- 2.1.4 Segment Outlook by Type
- 2.1.5 Segment Outlook by Application
- 2.1.6 Regional Outlook
- 2.1.7 Structural Developments Shaping the Forecast
- 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
- 3.1 Market Segmentation by Type
- 3.1.1 Market by Type Overview
- 3.1.2 30% Solution
- 3.1.3 50% Solution
- 3.1.4 ≥95% Crystals
- 3.1.5 Others
- 3.1.6 Volume Analysis
04Market Segmentation by Application
- 4.1 Market Segmentation by Application
- 4.1.1 Market by Application Overview
- 4.1.2 Pesticide Intermediate
- 4.1.3 Plant Growth Regulator
- 4.1.4 Pharmaceutical Intermediate
- 4.1.5 Others
- 4.1.6 Volume Analysis
05Regional Market Forecast
- Asia Pacific
- North America
- Europe
- Middle East & Africa
- Latin America
06Country-Level Market Forecast
- 6.1 Asia Pacific
- 6.1.1 China
- 6.1.2 Japan
- 6.1.3 Korea
- 6.1.4 Southeast Asia
- 6.1.5 India
- 6.1.6 Australia
- 6.1.7 Rest of Asia Pacific
- 6.2 North America
- 6.2.1 United States
- 6.2.2 Canada
- 6.2.3 Mexico
- 6.2.4 Rest of North America
- 6.3 Europe
- 6.3.1 Germany
- 6.3.2 France
- 6.3.3 UK
- 6.3.4 Italy
- 6.3.5 Russia
- 6.3.6 Rest of Europe
- 6.4 Middle East & Africa
- 6.4.1 Egypt
- 6.4.2 South Africa
- 6.4.3 Israel
- 6.4.4 Turkey
- 6.4.5 GCC Countries
- 6.4.6 Rest of Middle East & Africa
- 6.5 Latin America
- 6.5.1 Brazil
- 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
- 7.1 Growth Drivers & Inhibitors
- 7.1.1 Section Overview
- 7.1.2 Growth Drivers
- 7.1.3 Growth Inhibitors
- 7.1.4 Driver and Inhibitor Impact Assessment
- 7.1.5 Analyst Perspective
08Key Company Profiles
- 8.1 AlzChem Group AG (DE)
- 8.1.1 Company Overview
- 8.1.2 Key Products & Segments
- 8.1.3 Financial Performance (2023–2025)
- 8.1.4 Business Strategy
- 8.1.5 SWOT Analysis
- 8.1.6 Strategic Implications (2026–2032)
- 8.2 Nippon Carbide Industries Co., Ltd. (JP)
- 8.2.1 Company Overview
- 8.2.2 Key Products & Segments
- 8.2.3 Financial Performance (2023–2025)
- 8.2.4 Business Strategy
- 8.2.5 SWOT Analysis
- 8.2.6 Strategic Implications (2026–2032)
- 8.3 Ningxia Darong Industrial Group Co., Ltd. (CN)
- 8.3.1 Company Overview
- 8.3.2 Key Products & Segments
- 8.3.3 Financial Performance (2023–2025)
- 8.3.4 Business Strategy
- 8.3.5 SWOT Analysis
- 8.3.6 Strategic Implications (2026–2032)
- 8.4 Jiangsu Deda Petrochemical Technology Co., Ltd. (CN)
- 8.4.1 Company Overview
- 8.4.2 Key Products & Segments
- 8.4.3 Financial Performance (2023–2025)
- 8.4.4 Business Strategy
- 8.4.5 SWOT Analysis
- 8.4.6 Strategic Implications (2026–2032)
- 8.5 Rugao Zhongru New Material Technology Co., Ltd. (CN)
- 8.5.1 Company Overview
- 8.5.2 Key Products & Segments
- 8.5.3 Financial Performance (2023–2025)
- 8.5.4 Business Strategy
- 8.5.5 SWOT Analysis
- 8.5.6 Strategic Implications (2026–2032)
- 8.6 Yifeng New Materials Co., Ltd. (CN)
- 8.6.1 Company Overview
- 8.6.2 Key Products & Segments
- 8.6.3 Financial Performance (2023–2025)
- 8.6.4 Business Strategy
- 8.6.5 SWOT Analysis
- 8.6.6 Strategic Implications (2026–2032)
- 8.7 Ningxia Jiafeng Chemical Co., Ltd. (CN)
- 8.7.1 Company Overview
- 8.7.2 Key Products & Segments
- 8.7.3 Financial Performance (2023–2025)
- 8.7.4 Business Strategy
- 8.7.5 SWOT Analysis
- 8.7.6 Strategic Implications (2026–2032)
- 8.8 Shanxi Zhicheng Chemical Co., Ltd. (CN)
- 8.8.1 Company Overview
- 8.8.2 Key Products & Segments
- 8.8.3 Financial Performance (2023–2025)
- 8.8.4 Business Strategy
- 8.8.5 SWOT Analysis
- 8.8.6 Strategic Implications (2026–2032)
- 8.9 Ningxia Jinhaiyangguang Biotechnology Co., Ltd. (CN)
- 8.9.1 Company Overview
- 8.9.2 Key Products & Segments
- 8.9.3 Financial Performance (2023–2025)
- 8.9.4 Business Strategy
- 8.9.5 SWOT Analysis
- 8.9.6 Strategic Implications (2026–2032)
- 8.10 Ningxia Jinhua Chemical Co., Ltd. (CN)
- 8.10.1 Company Overview
- 8.10.2 Key Products & Segments
- 8.10.3 Financial Performance (2023–2025)
- 8.10.4 Business Strategy
- 8.10.5 SWOT Analysis
- 8.10.6 Strategic Implications (2026–2032)
- 8.11 Pingluo County Xiangmei Chemical Co., Ltd. (CN)
- 8.11.1 Company Overview
- 8.11.2 Key Products & Segments
- 8.11.3 Financial Performance (2023–2025)
- 8.11.4 Business Strategy
- 8.11.5 SWOT Analysis
- 8.11.6 Strategic Implications (2026–2032)
- 8.12 Ningxia Hengkang Technology Co., Ltd. (CN)
- 8.12.1 Company Overview
- 8.12.2 Key Products & Segments
- 8.12.3 Financial Performance (2023–2025)
- 8.12.4 Business Strategy
- 8.12.5 SWOT Analysis
- 8.12.6 Strategic Implications (2026–2032)
- 8.13 Ningxia Taikang Pharmaceutical Co., Ltd. (CN)
- 8.13.1 Company Overview
- 8.13.2 Key Products & Segments
- 8.13.3 Financial Performance (2023–2025)
- 8.13.4 Business Strategy
- 8.13.5 SWOT Analysis
- 8.13.6 Strategic Implications (2026–2032)
- 8.14 Ningxia Sikeda Biotechnology Co., Ltd. (CN)
- 8.14.1 Company Overview
- 8.14.2 Key Products & Segments
- 8.14.3 Financial Performance (2023–2025)
- 8.14.4 Business Strategy
- 8.14.5 SWOT Analysis
- 8.14.6 Strategic Implications (2026–2032)
- 8.15 Shanghai Baosui Chemical Co., Ltd. (CN)
- 8.15.1 Company Overview
- 8.15.2 Key Products & Segments
- 8.15.3 Financial Performance (2023–2025)
- 8.15.4 Business Strategy
- 8.15.5 SWOT Analysis
- 8.15.6 Strategic Implications (2026–2032)
- 8.16 Shandong Qiangsen Chemical Co., Ltd. (CN)
- 8.16.1 Company Overview
- 8.16.2 Key Products & Segments
- 8.16.3 Financial Performance (2023–2025)
- 8.16.4 Business Strategy
- 8.16.5 SWOT Analysis
- 8.16.6 Strategic Implications (2026–2032)
- 8.17 Jiangsu Xinsu New Materials Co., Ltd. (CN)
- 8.17.1 Company Overview
- 8.17.2 Key Products & Segments
- 8.17.3 Financial Performance (2023–2025)
- 8.17.4 Business Strategy
- 8.17.5 SWOT Analysis
- 8.17.6 Strategic Implications (2026–2032)
- 8.18 Suzhou Senfeida Chemical Co., Ltd. (CN)
- 8.18.1 Company Overview
- 8.18.2 Key Products & Segments
- 8.18.3 Financial Performance (2023–2025)
- 8.18.4 Business Strategy
- 8.18.5 SWOT Analysis
- 8.18.6 Strategic Implications (2026–2032)
09Competitive Landscape
- 9.1 Competitive Landscape Overview
- 9.2 Competitive Intensity Assessment
- 9.3 Key Player Strategies & Positioning
- 9.4 Competitive Dynamics & Strategic Outlook
- 9.4.1 Emerging Competitive Threats
- 9.4.2 Consolidation vs. Fragmentation Outlook
- 9.4.3 Competitive Response Matrix
- 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
- 10.1 Threat of New Entrants
- 10.2 Bargaining Power of Buyers
- 10.3 Bargaining Power of Suppliers
- 10.4 Threat of Substitutes
- 10.5 Competitive Rivalry
11PESTLE Analysis
- 11.1 Political
- 11.2 Economic
- 11.3 Social and Demographic
- 11.4 Technological
- 11.5 Legal and Regulatory
- 11.6 Environmental
- 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
- 13.1 Future Trends & Outlook
- 13.1.1 Trend Summary and Commercial Maturity Assessment
- 13.1.2 Technology and Innovation Trends
- 13.1.3 Long-Term Market Outlook
- 13.1.4 Investment & M&A Activity Outlook
- 13.1.5 Overall Outlook Assessment
Frequently asked questions
How big is the global Monocyanamide market?
How fast is the Monocyanamide market expected to grow?
What does the Monocyanamide market cover?
How is the Monocyanamide market segmented by type?
What are the key applications of Monocyanamide?
Which companies are profiled in the Monocyanamide market report?
What geographies does the Monocyanamide market analysis include?
What are the key demand drivers for Monocyanamide?
Who should buy the Monocyanamide market report?
What license options are available for this report?
Research Methodology
All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.
Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.
Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.
Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.
CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.
All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.
On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.
Need a customized version?
Get country-, segment- or company-specific intelligence tailored to your exact requirements.
Request custom research →Request a free sample
Receive a sample of Global Monocyanamide Market Strategic Research Report before you buy.
Customize This Report
Describe your specific requirements and our analysts will scope and deliver a tailored version.
Request Invoice
We will email a proforma invoice within 24 hours. Report access is granted upon payment confirmation.
Navadhi Market Research · Chemicals & Advanced Materials